Blood test that detects colon cancer close to receiving FDA approval

  • 📰 News12
  • ⏱ Reading Time:
  • 37 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 51%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Doctors and scientists say the Guardant Shield blood test could help identify more cases of colorectal cancer because people are more likely to take a blood test than undergo a colonoscopy.

A blood test that detects colon cancer is one step closer to being approved by the Food and Drug Administration.has been available for two years and costs $900 out of pocket. Earlier this week, seven out of nine doctors and scientists on a FDA advisory panel voted yes to approve the test for colorectal cancer screening.

They say the test could help identify more cases of colorectal cancer because people are more likely to take a blood test than undergo a colonoscopy. An estimated 60% of people skip a colonoscopy. Test results take close to two weeks. Data published New England Journal of Medicine show that the test was 83% effective in detecting colon cancer. However, expects say the test is not as accurate as a colonoscopy and would not replace it as the gold standard for colon cancer detection because the test is also not as successful in detecting pre-cancer.If Shield gets full approval by the FDA, it would be first approved blood screening test for colorectal cancer that meets requirements for Medicare reimbursement.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 591. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA panel recommends approval of a blood test for colon cancerReuters
Source: NBCNewsHealth - 🏆 707. / 51 Read more »

What to know about the blood test to detect colon cancer recommended by an FDA panelThe test's maker said the FDA will likely decide on approval later this year.
Source: ABC - 🏆 471. / 51 Read more »

Stocks making the biggest moves premarket: Ross Stores, Intuit, Workday, Guardant Health and moreThese are the stocks posting the largest moves in premarket trading.
Source: CNBC - 🏆 12. / 72 Read more »